BindingDB logo
myBDB logout

Patent code US8551963

Compile Data Set for Download or QSAR
Found 10 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103623
PNG
(US8551963, 1a)
Show SMILES CC(CO)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O6S/c1-29(17-36,18-37)25-15-26(33-41-25)32-27(38)30-20-4-2-19(3-5-20)22-16-35-23-7-6-21(14-24(23)42-28(35)31-22)40-13-10-34-8-11-39-12-9-34/h2-7,14-16,36-37H,8-13,17-18H2,1H3,(H2,30,32,33,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 2.20n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103622
PNG
(US8551963, I-1)
Show SMILES CC(C)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O5S/c1-29(2,18-36)25-16-26(33-40-25)32-27(37)30-20-5-3-19(4-6-20)22-17-35-23-8-7-21(15-24(23)41-28(35)31-22)39-14-11-34-9-12-38-13-10-34/h3-8,15-17,36H,9-14,18H2,1-2H3,(H2,30,32,33,37)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 5.5n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103622
PNG
(US8551963, I-1)
Show SMILES CC(C)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O5S/c1-29(2,18-36)25-16-26(33-40-25)32-27(37)30-20-5-3-19(4-6-20)22-17-35-23-8-7-21(15-24(23)41-28(35)31-22)39-14-11-34-9-12-38-13-10-34/h3-8,15-17,36H,9-14,18H2,1-2H3,(H2,30,32,33,37)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 0.770n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103622
PNG
(US8551963, I-1)
Show SMILES CC(C)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O5S/c1-29(2,18-36)25-16-26(33-40-25)32-27(37)30-20-5-3-19(4-6-20)22-17-35-23-8-7-21(15-24(23)41-28(35)31-22)39-14-11-34-9-12-38-13-10-34/h3-8,15-17,36H,9-14,18H2,1-2H3,(H2,30,32,33,37)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 1.90n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103622
PNG
(US8551963, I-1)
Show SMILES CC(C)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O5S/c1-29(2,18-36)25-16-26(33-40-25)32-27(37)30-20-5-3-19(4-6-20)22-17-35-23-8-7-21(15-24(23)41-28(35)31-22)39-14-11-34-9-12-38-13-10-34/h3-8,15-17,36H,9-14,18H2,1-2H3,(H2,30,32,33,37)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 0.680n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103623
PNG
(US8551963, 1a)
Show SMILES CC(CO)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O6S/c1-29(17-36,18-37)25-15-26(33-41-25)32-27(38)30-20-4-2-19(3-5-20)22-16-35-23-7-6-21(14-24(23)42-28(35)31-22)40-13-10-34-8-11-39-12-9-34/h2-7,14-16,36-37H,8-13,17-18H2,1H3,(H2,30,32,33,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 4.10n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103623
PNG
(US8551963, 1a)
Show SMILES CC(CO)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O6S/c1-29(17-36,18-37)25-15-26(33-41-25)32-27(38)30-20-4-2-19(3-5-20)22-16-35-23-7-6-21(14-24(23)42-28(35)31-22)40-13-10-34-8-11-39-12-9-34/h2-7,14-16,36-37H,8-13,17-18H2,1H3,(H2,30,32,33,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 7.10n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103623
PNG
(US8551963, 1a)
Show SMILES CC(CO)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O6S/c1-29(17-36,18-37)25-15-26(33-41-25)32-27(38)30-20-4-2-19(3-5-20)22-16-35-23-7-6-21(14-24(23)42-28(35)31-22)40-13-10-34-8-11-39-12-9-34/h2-7,14-16,36-37H,8-13,17-18H2,1H3,(H2,30,32,33,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 1.60n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103623
PNG
(US8551963, 1a)
Show SMILES CC(CO)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O6S/c1-29(17-36,18-37)25-15-26(33-41-25)32-27(38)30-20-4-2-19(3-5-20)22-16-35-23-7-6-21(14-24(23)42-28(35)31-22)40-13-10-34-8-11-39-12-9-34/h2-7,14-16,36-37H,8-13,17-18H2,1H3,(H2,30,32,33,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 3.70n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM103622
PNG
(US8551963, I-1)
Show SMILES CC(C)(CO)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1
Show InChI InChI=1S/C29H32N6O5S/c1-29(2,18-36)25-16-26(33-40-25)32-27(37)30-20-5-3-19(4-6-20)22-17-35-23-8-7-21(15-24(23)41-28(35)31-22)39-14-11-34-9-12-38-13-10-34/h3-8,15-17,36H,9-14,18H2,1-2H3,(H2,30,32,33,37)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/a 0.690n/an/an/an/an/a



Ambit Biosciences Corporation

US Patent


Assay Description
Competition binding assay used herein were developed validated and performed as described in Fabian et al., Nature Biotechnology 2005, 23, 329-336.


US Patent US8551963 (2013)


BindingDB Entry DOI: 10.7270/Q23F4N7J
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%